Hostname: page-component-77c89778f8-5wvtr Total loading time: 0 Render date: 2024-07-24T20:10:07.110Z Has data issue: false hasContentIssue false
  • English
  • Français

The Evaluation and Control of Drugs in Norway

Published online by Cambridge University Press:  10 March 2009

Bjørn Jøldal
Bjørn Jøldal
Affiliation:
Directorate of Health, Norway
Get access Rights & Permissions [Opens in a new window]

Extract

The basic aim of a drug policy is to ensure that effective and safe drugs of good quality are available to cover the health needs of a country. A national drug policy should be considered an integral part of any comprehensive health-care policy. The formulation of national drug policies varies even between similar countries because of conflicting interests and different political, economic, and social pressures. It is influenced by such factors as:

the health situation of the country;

the medical care system;

the education and training of health personnel;

the social security and health-insurance schemes;

drug research and development possibilities;

the domestic production of drugs;

the determination of the demand for drugs;

the system of drug distribution;

the possibilities for evaluation and control of drugs; and

international policies on medicinal products.

Type
Special Section: The Evaluation of Drugs: An International Perspective
Information
International Journal of Technology Assessment in Health Care , Volume 2 , Issue 4 , October 1986 , pp. 663 - 671
Copyright
Copyright © Cambridge University Press 1986

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

REFERENCES

1Jøldal, B.Selecting drugs on the basis of need. World Health Forum, 1985, 6.Google Scholar
2Jøldal, B. Procurement and pricing of drugs in Norway. Paper presented at a WHO meeting on Procurement and Financing of Essential Drugs. Madrid, 22–26 October 1984 (unpublished).Google Scholar
3Jøldal, B., & Halvorsen, I.Sales statistics in the control of drug abuse in Norway. Bulletin on Narcotics, 1982, 34, 2, 57–68.Google ScholarPubMed
4Nordic Council on Medicines. Nordic statistics on medicines 1978–1980, part II, Nordic Council on Medicines, 1982.Google Scholar
5World Health Organization. The selection of essential drugs. (Technical Report Series, No. 615.) Geneva: World Health Organization, 1977.Google Scholar